Cite
Comparisons of cancer staging systems should be based on overall performance in the population.
MLA
Kerr, Kathleen F., et al. “Comparisons of Cancer Staging Systems Should Be Based on Overall Performance in the Population.” Clinical Trials (London, England), vol. 14, no. 6, Dec. 2017, pp. 659–60. EBSCOhost, https://doi.org/10.1177/1740774517722141.
APA
Kerr, K. F., LeBlanc, M., & Janes, H. (2017). Comparisons of cancer staging systems should be based on overall performance in the population. Clinical Trials (London, England), 14(6), 659–660. https://doi.org/10.1177/1740774517722141
Chicago
Kerr, Kathleen F, Michael LeBlanc, and Holly Janes. 2017. “Comparisons of Cancer Staging Systems Should Be Based on Overall Performance in the Population.” Clinical Trials (London, England) 14 (6): 659–60. doi:10.1177/1740774517722141.